Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 7, p. 394, doi. 10.1038/cgt.2013.34
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2013 AND VI 20 AND IP 7
Results: 6
1
2
Nicotinamide mononucleotide adenylyltransferase overexpression enhances colorectal cancer cell-kill by Tiazofurin.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 7, p. 403, doi. 10.1038/cgt.2013.33
- By:
- Publication type:
- Article
3
Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 7, p. 421, doi. 10.1038/cgt.2013.31
- By:
- Publication type:
- Article
4
Gene silencing of A-kinase anchor protein 4 inhibits cervical cancer growth in vitro and in vivo.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 7, p. 413, doi. 10.1038/cgt.2013.32
- By:
- Publication type:
- Article
5
Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 7, p. 386, doi. 10.1038/cgt.2013.35
- By:
- Publication type:
- Article
6
The glioma-associated oncogene homolog 1 promotes epithelial-mesenchymal transition in human esophageal squamous cell cancer by inhibiting E-cadherin via Snail.
- Published in:
- Cancer Gene Therapy, 2013, v. 20, n. 7, p. 379, doi. 10.1038/cgt.2013.36
- By:
- Publication type:
- Article